0001209191-18-020365.txt : 20180316
0001209191-18-020365.hdr.sgml : 20180316
20180316183202
ACCESSION NUMBER: 0001209191-18-020365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Altmeyer Mark
CENTRAL INDEX KEY: 0001643074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37418
FILM NUMBER: 18697005
MAIL ADDRESS:
STREET 1: C/O AXOVANT SCIENCES, INC.
STREET 2: 1441 BROADWAY, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axovant Sciences Ltd.
CENTRAL INDEX KEY: 0001636050
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 20-22 BEDFORD ROW
CITY: LONDON
STATE: X0
ZIP: WC1R 4JS
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: 20-22 BEDFORD ROW
CITY: LONDON
STATE: X0
ZIP: WC1R 4JS
FORMER COMPANY:
FORMER CONFORMED NAME: Axovant Sciences, Inc.
DATE OF NAME CHANGE: 20150324
FORMER COMPANY:
FORMER CONFORMED NAME: Roivant Neurosciences Ltd.
DATE OF NAME CHANGE: 20150309
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-15
0
0001636050
Axovant Sciences Ltd.
AXON
0001643074
Altmeyer Mark
C/O AXOVANT SCIENCES, INC.,
11 TIMES SQUARE, 33RD FLOR
NEW YORK
NY
10036
0
1
0
0
Pres (ASG) & Chief Comm. Ofc.
Employee Stock Option (Right to Buy)
1.46
2018-03-15
4
A
0
340000
0.00
A
2028-03-15
Common Shares
340000
340000
D
Employee Stock Option (Right to Buy)
1.46
2018-03-15
4
A
0
100000
0.00
A
2028-03-15
Common Shares
100000
100000
D
The option vests over a period of four years, with one quarter of the common shares underlying the option vesting on March 15, 2019 and the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
One-third of the option will vest at such time as the Issuer's stock price is equal to $4.38; one-third of the option will vest at such time as the Issuer's stock price is equal to $7.30, and one-third of the option will vest at such time as the Issuer's stock price is equal to $10.22, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date.
/s/ Gregory Weinhoff, Attorney-in-Fact
2018-03-16